Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “MCRPC (metastatic Castration-resistant Prostate Cancer)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT03732820
What this trial is testing

Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
AstraZeneca 895
Testing effectiveness (Phase 2)Looking for participantsNCT07594106
What this trial is testing

REGN15505 (PSMAx4-1BB) Alone or in Combination With Cemiplimab or REGN4336 (PSMAxCD3) in Adult Patients With Metastatic Castration-Resistant Prostate Cancer and Clear Cell Renal Cell Carcinoma

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer (mCRPC)Clear Cell Renal Cell Carcinoma (ccRCC)
Regeneron Pharmaceuticals 265
Large-scale testing (Phase 3)Active Not RecruitingNCT04446117
What this trial is testing

Study of Cabozantinib in Combination With Atezolizumab Versus Second NHT in Subjects With mCRPC

Who this might be right for
Metastatic Prostate CancerProstate Adenocarcinoma
Exelixis 575
Not applicableLooking for participantsNCT06659926
What this trial is testing

The Radium-select Study

Who this might be right for
mCRPCMale Urogenital Diseases
The Netherlands Cancer Institute 60
Not applicableStudy completedNCT03328364
What this trial is testing

A Registry Based Study Evaluating Overall Survival and Treatment Length in mCRPC Patients Treated With Enzalutamide in Sweden

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
Astellas Pharma a/s 211
Large-scale testing (Phase 3)Study completedNCT03834519
What this trial is testing

Study of Pembrolizumab (MK-3475) Plus Olaparib Versus Abiraterone Acetate or Enzalutamide in Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-7339-010/KEYLYNK-010)

Who this might be right for
Prostatic Neoplasms
Merck Sharp & Dohme LLC 793
Early research (Phase 1)Ended earlyNCT05673109
What this trial is testing

AC176 for the Treatment of Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
Accutar Biotechnology Inc 8
Early research (Phase 1)Study completedNCT01400555
What this trial is testing

A Safety Study of Abiraterone Acetate Administered in Combination With Docetaxel in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Who this might be right for
Prostate NeoplasmsProstate Cancer
Cougar Biotechnology, Inc. 22
Early research (Phase 1)Ended earlyNCT04404140
What this trial is testing

A Study Evaluating The Safety, Efficacy and Pharmacokinetics Of Ipatasertib In Combination With Atezolizumab And Docetaxel In Metastatic Castration-Resistant Prostate Cancer (mCRPC).

Who this might be right for
Castration-Resistant Prostatic Cancer
Hoffmann-La Roche 6
Early research (Phase 1)Active Not RecruitingNCT03874884
What this trial is testing

177Lu-PSMA-617 Therapy and Olaparib in Patients With Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Metastatic Castration Resistant Prostate Cancer (mCRPC)
Peter MacCallum Cancer Centre, Australia 70
Early research (Phase 1)UnknownNCT04108247
What this trial is testing

Abiraterone in Combination With SHR3162 in the Treatment of mCRPC

Who this might be right for
Prostate Cancer Castration-resistant Prostate Cancer
Jiangsu HengRui Medicine Co., Ltd. 39
Early research (Phase 1)Active Not RecruitingNCT02123758
What this trial is testing

JNJ-56021927 (ARN-509) and Abiraterone Acetate in Participants With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Prostatic NeoplasmsMetastatic Castration-Resistant Prostate Cancer
Aragon Pharmaceuticals, Inc. 57
Testing effectiveness (Phase 2)Active Not RecruitingNCT05340374
What this trial is testing

Cabazitaxel in Combination With 177Lu-PSMA-617 in Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate CancermCRPC
Peter MacCallum Cancer Centre, Australia 35
Testing effectiveness (Phase 2)Looking for participantsNCT07414940
What this trial is testing

ACTinium in Castrate-RESistant Prostate Cancer After LUTEtium

Who this might be right for
Metastatic Castration-resistant Prostate CancerMetastatic Prostate CancerProstate Cancer
University College, London 60
Testing effectiveness (Phase 2)Study completedNCT03103724
What this trial is testing

A Phase II Study Evaluating the Efficacy of Enzalutamide and the Role of ARv7 in Metastatic Castration Resistant Prostate Cancer (mCRPC) Patients With Visceral Disease.

Who this might be right for
Carcinoma Prostate
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 68
Testing effectiveness (Phase 2)Looking for participantsNCT05393791
What this trial is testing

Phase II Randomised Controlled Trial of Patient-specific Adaptive vs. Continuous Abiraterone or eNZalutamide in mCRPC

Who this might be right for
Prostatic Neoplasms, Castration-Resistant
Leiden University Medical Center 168
Testing effectiveness (Phase 2)Study completedNCT04028388
What this trial is testing

ModraDoc006/r vs Docetaxel IV in Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer MetastaticCastration-resistant Prostate Cancer
Modra Pharmaceuticals 135
Testing effectiveness (Phase 2)Study completedNCT02125357
What this trial is testing

Sequencing Abiraterone and Enzalutamide in mCRPC

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer
British Columbia Cancer Agency 202
Very early researchStudy completedNCT02115828
What this trial is testing

Vismodegib in Men With Metastatic CRPC With Accessible Metastatic Lesions for Tumor Biopsy

Who this might be right for
Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 9
Not applicableUnknownNCT03934164
What this trial is testing

Molecular Stratification Profiling Protocol in Metastatic Castration Resistant Prostate Cancer (mCRPC) - MAESTRO

Who this might be right for
Metastatic Prostate CancerCastration-resistant Prostate Cancer
Institute of Cancer Research, United Kingdom 600
Next Page